EFAVIRENZ
Disclaimer: These predictions are for research purposes only. They do not constitute medical advice and require clinical validation.
Overview
| Property | Value |
|---|---|
| Drug Name | EFAVIRENZ |
| DrugBank ID | DB00625 |
| HSA Status | Registered with Health Sciences Authority |
| KG Predictions | 18 |
| DL Predictions (≥0.7) | 34 |
Predicted Indications
The following indications are predicted based on TxGNN knowledge graph analysis:
| Indication | Source | Evidence |
|---|---|---|
| plasma cell myeloma | TxGNN Knowledge Graph | L5 |
| cystic fibrosis | TxGNN Knowledge Graph | L5 |
| pulmonary tuberculosis | TxGNN Knowledge Graph | L5 |
| obsessive-compulsive disorder | TxGNN Knowledge Graph | L5 |
| phobic disorder | TxGNN Knowledge Graph | L5 |
| social phobia | TxGNN Knowledge Graph | L5 |
| papillary conjunctivitis | TxGNN Knowledge Graph | L5 |
| allergic rhinitis | TxGNN Knowledge Graph | L5 |
| nasopharyngitis | TxGNN Knowledge Graph | L5 |
| pharyngitis | TxGNN Knowledge Graph | L5 |
Evidence Summary
External Resources
Generated by SgTxGNN on 2026-03-11